Abstract: The present invention is related to silicon nanoparticles, a pharmaceutical composition comprising silicon nanoparticles, a method for synthesis of the silicon nanoparticles and their use for in vivo diagnostics, visualization of drug delivery or staining of cells, biological processes or pathways. The silicon nanoparticles are characterized that they comprise a silicon core of a size of 1 to 10 nm and are terminated with allylamine or poly(allylamine) comprising up to 10 allylamine groups.

Abstract: The present invention is related to silicon nanoparticles, a pharmaceutical composition comprising silicon nanoparticles, a method for synthesis of the silicon nanoparticles and their use for in vivo diagnostics, visualization of drug delivery or staining of cells, biological processes or pathways. The silicon nanoparticles are characterised that they comprise a silicon core of a size of 1 to 10 nm and are terminated with allylamine or poly(allylamine) comprising up to 10 allylamine groups.

Abstract: A method and system for analyzing interlinked production processes for manufacturing a product are provided. Static and dynamic input data for at least one product parameter or process parameter are acquired. At least one degree of freedom of the at least one product parameter or process parameter is determined. At least one target parameter is acquired. The acquired static and dynamic input data are processed on the basis of at least one degree of freedom and, the at least one product parameter or process parameter is automatically adjusted. At least some of the data determined and acquired are stored or output.

Abstract: A method and system for analyzing interlinked production processes for manufacturing a product are provided. Static and dynamic input data for at least one product parameter or process parameter are acquired. At least one degree of freedom of the at least one product parameter or process parameter is determined. At least one target parameter is acquired. The acquired static and dynamic input data are processed on the basis of at least one degree of freedom and, the at least one product parameter or process parameter is automatically adjusted. At least some of the data determined and acquired in steps a) to d) are stored or output.

Abstract: The invention relates to specific radioactive metal complexes based on bispidine and the derivatives thereof as chelating agents, the use thereof for nuclear medical diagnosis and therapy, and a method for producing such radioactive metal complexes.